[Form 4] Alto Ingredients, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Alto Ingredients insider James R. Sneed, the company’s Chief Commercial Officer and a director, purchased 3,176 shares of common stock at $1.0593 per share on 08/13/2025. After the transaction he directly beneficially owns 432,397 shares. The Form 4 reports this routine insider acquisition and shows no derivatives or other transactions.

Insights

Financial Analyst

TL;DR: Small insider purchase increases direct stake to 432,397 shares; transaction appears routine and not materially transformative.

The reported purchase of 3,176 shares at $1.0593 is a modest open-market acquisition by a senior officer and director. Given the size relative to total post-transaction holdings, this disclosure is informative about insider activity but unlikely to materially affect valuation or capital structure. No derivative positions or dispositions were reported, limiting complexity.

Corporate Governance Expert

TL;DR: Insider compliance is evident; the filing documents a standard Section 16 disclosure for an officer/director purchase.

The Form 4 is properly signed and indicates the reporting person filed individually. The transaction code shows a purchase (P) and the filing records direct ownership. There are no indications of coordinated group filings, plans, or Rule 10b5-1 reliance in the reported fields. This represents routine transparency under insider trading rules.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sneed James R

(Last) (First) (Middle)

1300 SOUTH SECOND STREET

(Street)

PEKIN IL 61554

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alto Ingredients, Inc. [ ALTO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		P		3,176	A	$1.0593	432,397	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ James R. Sneed	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did James R. Sneed report for ALTO?

He reported a purchase of 3,176 shares of ALTO common stock at $1.0593 per share on 08/13/2025.

How many ALTO shares does James R. Sneed own after the reported trade?

Following the transaction he directly beneficially owns 432,397 shares.

Did the Form 4 report any derivative securities or option transactions for ALTO?

No. Table II shows no derivative securities acquired, disposed of, or beneficially owned in this filing.

What is James R. Sneed’s role at Alto Ingredients (ALTO)?

He is reported as a Director and the company’s Chief Commercial Officer.